Advertisement
| dendritic cell therapy cost: Immunopharmacogenomics Yusuke Nakamura, 2015-09-18 This book proposes immunogenomics, or immunopharmacogenomics, as the next-generation big science to uncover the role that the immune system plays in the pathogenesis of many diseases, by summarizing the importance of the deep sequencing of T-cell and B-cell receptors. Immunogenomics/immunopharmacogenomics, a genetic characterization of the immune system made possible by next-generation sequencing (NGS), will be important for the further understanding of the pathogenesis of various disease conditions. Abnormal immune responses in the body lead to development of autoimmune diseases and food allergies. Rejection of recipient cells and tissues, as well as severe immune reactions to donor cells, is also the result of uncontrolled immune responses in the recipient body. There have been many reports indicating that activated immune responses caused by the interaction of drugs and HLA are present in drug-induced skin hypersensitivity and liver toxicity. The importance of the host immune responses has been recognized in cancer treatments, not only for immunotherapy but also for cytotoxic agents and molecular targeted drugs. Hence, characterization of the T-cell receptor and B-cell receptor repertoire by means of NGS deep sequencing will ultimately make possible the identification of the molecular mechanisms that underlie various diseases and drug responses. In addition, this approach may contribute to the identification of antigens associated with the onset or progression of autoimmune diseases as well as food allergies. Although the germline alterations and somatic mutations have been extensively analyzed, changes or alterations of the immune responses during the course of various disease conditions or during various treatments have not been analyzed. It is also clear that computational analyses to draw meaningful inferences of functional recognition receptors on the immune cells remain a huge challenge. |
| dendritic cell therapy cost: Tolerogenic Dendritic Cells and Regulatory T Cells as Therapeutics for Immune-Mediated Disorders Djordje Miljkovic, Piotr Trzonkowski, 2021-11-16 |
| dendritic cell therapy cost: Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers? Stephen P. Cobbold, Xian C. Li, This Research Topic is a call for papers to provide an up to date assessment of current attempts to introduce tolerogenic therapies into clinical practice. Tolerance has been a highly sought after goal in the field of organ transplantation for over half a century, and is now readily achievable in rodent models, but considerable barriers remain to successfully translating tolerogenic treatments to the clinic. The initial call for this Research Topic has been aimed to provide an overview of recent advances made within the European RISET and American ITN networks with regard to tolerogenic strategies in clinical transplantation, autoimmune disease, and allergy. Articles will also cover the barriers to clinical tolerance induction and new emerging approaches to overcome such barriers. 1. Collaborative networks working towards the goal of therapeutic tolerance induction 2. Prope tolerance and minimization of immunosuppression 3. Lessons from operationally tolerant patients 4. Targeted withdrawal of immunosuppression 5. Stem cells and hematopoietic chimerism as a route to tolerance 6. Promoting regulatory T cells 7. Tolerogenic dendritic cells and negative vaccination 8. Inhibitory pathways and mechanisms in tolerance 9. Memory T cells and heterologous immunity 10. The innate response to allotransplants 11. Chronic graft loss--what are the missing links? 12. The impact of graft microenvironment on tolerance |
| dendritic cell therapy cost: New Horizons in Tumor Microenvironment Biology and Therapy: Implications for New Therapies Vol. II Andreas Pircher, Dominik Wolf, 2022-08-19 |
| dendritic cell therapy cost: Cell and Gene Therapies Miguel-Angel Perales, Syed A. Abutalib, Catherine Bollard, 2018-11-27 In this book, experts in the field express their well-reasoned opinions on a range of complex, clinically relevant issues across the full spectrum of cell and gene therapies with the aim of providing trainee and practicing hematologists, including hematopoietic transplant physicians, with information that is relevant to clinical practice and ongoing research. Each chapter focuses on a particular topic, and the concise text is supported by numerous working tables, algorithms, and figures. Whenever appropriate, guidance is provided regarding the availability of potentially high-impact clinical trials. The rapid evolution of cell and gene therapies is giving rise to numerous controversies that need to be carefully addressed. In meeting this challenge, this book will appeal to all residents, fellows, and faculty members responsible for the care of hematopoietic cell transplant patients. It will also offer a robust, engaging tool to aid vital activities in the daily work of every hematology and oncology trainee. |
| dendritic cell therapy cost: Progress in Cancer Immunotherapy Shuren Zhang, 2016-05-30 This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors. |
| dendritic cell therapy cost: Journal of the National Cancer Institute , 2000 |
| dendritic cell therapy cost: Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book Daniel W. Lee, Nirali N. Shah, 2019-11-30 From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area. - Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care. - Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. - Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon. - Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy. |
| dendritic cell therapy cost: Handbook of Molecular Biotechnology Dongyou Liu, 2024-09-05 With a history that likely dates back to the dawn of human civilization more than 10,000 years ago, and a record that includes the domestication and selective breeding of plants and animals, the harnessing of fermentation process for bread, cheese, and brewage production, and the development of vaccines against infectious diseases, biotechnology has acquired a molecular focus during the 20th century, particularly following the resolution of DNA double helix in 1953, and the publication of DNA cloning protocol in 1973, and transformed our concepts and practices in disease diagnosis, treatment and prevention, pharmaceutical and industrial manufacturing, animal and plant industry, and food processing. While molecular biotechnology offers unlimited opportunities for improving human health and well-being, animal welfare, agricultural innovation and environmental conservation, a dearth of high quality books that have the clarity of laboratory manuals without distractive procedural details and the thoroughness of well-conversed textbooks appears to dampen the enthusiasm of aspiring students. In attempt to fill this glaring gap, Handbook of Molecular Biotechnology includes four sections, with the first three presenting in-depth coverage on DNA, RNA and protein technologies, and the fourth highlighting their utility in biotechnology. Recognizing the importance of logical reasoning and experimental verification over direct observation and simple description in biotechnological research and development, the Introduction provides pertinent discussions on key strategies (i.e., be first, be better, and be different), effective thinking (lateral, parallel, causal, reverse, and random), and experimental execution, which have proven invaluable in helping advance research projects, evaluate and prepare research reports, and enhance other scientific endeavors. Key features Presents state-of-the-art reviews on DNA, RNA and protein technologies and their biotechnological applications Discusses key strategies, effective thinking, and experimental execution for scientific research and development Fills the gap left by detailed-ridden laboratory manuals and insight-lacking standard textbooks Includes expert contributions from international scientists at the forefront of molecular biotechnology research and development Written by international scientists at the forefront of molecular biotechnology research and development, chapters in this volume cover the histories, principles, and applications of individual techniques/technologies, and constitute stand-alone, yet interlinked lectures that strive to educate as well as to entertain. Besides providing an informative textbook for tertiary students in molecular biotechnology and related fields, this volume serves as an indispensable roadmap for novice scientists in their efforts to acquire innovative skills and establish solid track records in molecular biotechnology, and offers a contemporary reference for scholars, educators, and policymakers wishing to keep in touch with recent developments in molecular biotechnology. |
| dendritic cell therapy cost: THERAPY FOR CBAVD USING CLUSTER OF DIFFERENTIATION A New Potential of Dendritic Cells Maslichah Mafruchati, 2024-08-01 Buku berjudul Terapi CBAVD menggunakan Cluster of Differentiation: Potensi Baru Sel Dendritik. Buku ini telah ditulis oleh seseorang yang ahli dibidangnya dan sudah memilikinya publikasi ilmiah baik nasional maupun Internasional. |
| dendritic cell therapy cost: Index Medicus , 2004 Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings. |
| dendritic cell therapy cost: Practical Transfusion Medicine Michael F. Murphy, David J. Roberts, Mark H. Yazer, 2017-03-22 The fifth edition of this practical textbook on transfusion medicine has been thoroughly revised with the latest in scientific and technological developments and edited by a leading team of international expert haematologists, including new co-editor Mark H. Yazer MD. A succinct and user-friendly resource of transfusion medicine for clinicians, scientists and trainees with key points, charts and algorithms Discusses practice in blood centres and hospitals including regulatory aspects, transfusion safety, production and storage, donor care, and blood transfusion in a global context Coverage of cellular and tissue therapies and organ transplantation including stem cell collection and haematopoietic stem cell processing and storage Review of the development of the evidence-base for transfusion medicine Content on the clinical practice for transfusion and alternatives to transfusion |
| dendritic cell therapy cost: Second Generation Cell and Gene-Based Therapies Alain Vertes, Nathan J. Dowden, Devyn Smith, Nasib Qureshi, 2020-02-07 Second Generation Cell and Gene-Based Therapies: Biological Advances, Clinical Outcomes, and Strategies for Capitalisation serves as the only volume to the market to bridge basic science, clinical therapy, technology development, and business in the field of cellular therapy/cytotherapy. After more than two decades of painstaking fundamental research, the concept of therapeutic cells (stem cells, genes, etc.), beyond the concept of vaccines, is reaching clinical trial, with mounting confidence in the safety and efficacy of these products. Nonetheless, numerous incremental technical advances remain to be achieved. Thus, this volume highlights the possible R&D paths, which will ultimately facilitate clinical delivery of cutting edge curative products.The next waves of innovation are reviewed in depth for hematopoietic stem cells, mesenchymal stem cells, tissue engineering, CAR-T cells, and cells of the immune system, as well as for enabling technologies such as gene and genome editing. Additionally, deep dives in product fundamentals, history of science, pathobiology of diseases, scientific and technological bases, and financing and technology adoption constraints are taken to unravel what will shape the cytotherapy industry to the horizon 2025 and beyond. The outcome is not simply a scientific book, but a global perspective on the nascent field combining science, business, and strategic fundamentals. - Helps readers learn about the most current trends in cell-based therapy, their overall effectiveness from a clinical prospective, and how the industry is moving therapies forward for capitalization - Perspectives section at the end of each chapter summarizes key learnings, hypotheses, and objectives highlighted and combines scientific and business insights - Edited and authored by scientists representing both basic and clinical research and industry, presenting a complete story of the current state and future promise of cellular therapies |
| dendritic cell therapy cost: 40th Annual Meeting of the American Society of Clinical Oncology American Society of Clinical Oncology. Annual Meeting, American Society of Clinical Oncology, 2004 |
| dendritic cell therapy cost: Vaccines for Cancer Immunotherapy Nima Rezaei, Mahsa Keshavarz-Fathi, 2018-10-17 Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines. - Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer - Presents the status of past and current vaccines for cancer treatment - Considers advantages and disadvantages of different therapeutic cancer vaccines - Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods - Analyzes obstacles to development of therapeutic cancer vaccines - Gives a view on future perspectives in the application of therapeutic cancer vaccines |
| dendritic cell therapy cost: Cancer Biology and Advances in Treatment Phuc Van Pham, 2020-10-14 This new series, based on a bi-annual conference and its topics, represents a major contribution to the emerging science of cancer research and regenerative medicine. Each volume brings together some of the most pre-eminent scientists working on cancer biology, cancer treatment, cancer diagnosis, cancer prevention and regenerative medicine to share information on currently ongoing work which will help shape future therapies. These volumes are invaluable resources not only for already active researchers or clinicians but also for those entering these fields, plus those in industry. Cancer Biology and Advances in Treatment is a proceedings volume which reflects papers presented at the 3rd bi-annual Innovations in Regenerative Medicine and Cancer Research conference; taken with its companion volume Tissue Engineering and Regenerative Medicine and Stem Cells: Biology and Engineering it provides a complete overview of the papers from that meeting of international experts. |
| dendritic cell therapy cost: Roitt's Essential Immunology Peter J. Delves, Seamus J. Martin, Dennis R. Burton, Ivan M. Roitt, 2016-11-15 Roitt's Essential Immunology - the textbook of choice for students and instructors of immunology worldwide Roitt’s Essential Immunology clearly explains the key principles needed by medical and health sciences students, from the basis of immunity to clinical applications. A brand new introduction sets the scene to section 1, Fundamentals of Immunology, introducing the microbial world and the strategies the body employs to defend itself. Each chapter then guides the reader through a different part of the immune system, and explains the role of each cell or molecule individually, and then as a whole. Section 2, Applied Immunology, discusses what happens when things go wrong, and the role the immune system plays alongside the damaging effects of a disease, including cancer, immunodeficiency, allergies and transplantation and the beneficial effects of vaccines. The 13th edition continues to be a user-friendly and engaging introduction to the workings of the immune system, whilst supporting those who require a slightly more detailed understanding of the key developments in immunology. The content has been fully updated throughout and includes: An expansion on key clinical topics, including: innate immunity, autoimmune conditions, asthma, primary immunodeficiency, and HIV/AIDS Beautifully presented with improved artwork and new illustrations A range of learning features, including introduction re-cap boxes, end of chapter and section summaries to aid revision, as well as further reading suggestions, and a glossary to explain the most important immunology terms. Roitt's Essential Immunology is also supported by a companion website at www.roitt.com including: An additional online only chapter on immunological methods and applications Further interactive multiple choice and single best answer questions for each chapter Animations and videos showing key concepts Fully downloadable figures and illustrations, further reading and useful links Updated extracts from the Encyclopaedia of Life Sciences Podcasts to reinforce the key principles explained in the text |
| dendritic cell therapy cost: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies Guido Moll, Martin Johannes Hoogduijn, James A. Ankrum, 2020-07-24 |
| dendritic cell therapy cost: Bio-Engineering Approaches to Cancer Diagnosis and Treatment Azadeh Shahidian, Majid Ghassemi, Javad Mohammadi, Mohadeseh Hashemi, 2020-05-14 Bioengineering Approaches to Cancer Diagnosis and Treatment is written for an audience of senior undergraduate students and graduate students in mechanical, electrical and biomedical engineering fields and other professionals in medicine. It is ideally structured for teaching and for those who are working in cancer bioengineering or interdisciplinary projects. The book's authors bring a unique perspective from their expertise in immunology, nanobiomaterials and heat transfer. Topical coverage includes an introduction to the fundamentals of bioengineering and engineering approaches for cancer diagnosis, cancer treatment via case studies, and sections on imaging, immunotherapy, cell therapy, drug delivery, ultrasound and microfluidics in cancer treatment. - Provides fully supported case studies relating to cancer diagnosis and therapy - Pairs the basic fundamentals of engineering and biomedical engineering and applies them to the diagnosis of cancer |
| dendritic cell therapy cost: Cell Therapy Dwaine F. Emerich, Gorka Orive, 2017-08-25 This volume provides a comprehensive, state-of-the art review of the field of cell therapy. The volume begins with an overview of the breadth of the field and then turns to overviews of imaging technologies that can aid in both safety and efficacy evaluations. The book then turns to numerous contributions detailing the rapidly growing field of stem cell therapies. These sections cover our understanding of the natural roles of stem cells in biology and human disease and then touches on several of the more prominent areas where stem cells are moving rapidly into clinical evaluation including neurodegenerative diseases, muscular dystrophy, cardiac repair, and diabetes. The volume concludes with contributions from experts in oncology, ophthalmology, stem cells, 3-D printing, and biomaterials where the convergence of expertise is leading to unprecedented insights into how to minutely control the in vivo fate and function of transplanted and/or endogeneously mobilized cells. Finally, the book provides insights into the pivotal relationship between academic and industrial partnerships. This volume is designed to touch on the major areas where the field will make its greatest and most immediate clinical impacts. This text will provide a useful resource for physicians and researchers interested in the rapidly changing filed of cell therapy. |
| dendritic cell therapy cost: Journal of the National Cancer Institute , 2001 Summaries of papers contained in the journal accompany each issue, 19-- |
| dendritic cell therapy cost: Clinical Translation and Commercialisation of Advanced Therapy Medicinal Products Tracy Tong Li Yu, Yves Bayon, Alain A. Vertes, Ivan Martin, 2021-01-21 Dr. Yves Bayon is a Senior Principal Scientist at Medtronic and Dr. Alain Vertes is affiliated with NxR Biotechnologies GmbH. All other Topic Editors declare no competing interests with regards to the Research Topic subject. |
| dendritic cell therapy cost: Clinical Equine Oncology Derek C. Knottenbelt, Katie Snalune, Janet Patterson Kane, 2015-03-26 Diagnose common equine tumors accurately and find clinical information quickly! Clinical Equine Oncology describes the cellular basis of cancer and its etiopathogenesis, along with the principles of diagnosis, treatment, and management of cancer cases. This comprehensive resource offers more than just facts and diagrams — hundreds of detailed photographs make it easier to recognize and evaluate more than 50 types of tumors. It's useful to anyone working in the equine field, whether you're a veterinary surgeon, a practicing vet, equine dentist, or veterinary student. Written by a recognized expert on equine medicine, Derek Knottenbelt, this is the only book on the market that is completely dedicated to coverage of cancer in horses! - More than 50 different types of tumor are covered, including tumors that occur in each of the 10 body systems. - Over 800 excellent-quality photographs show the appearance of pathologies and cancerous conditions both before and after treatment. - More than 80 full-color diagrams summarize key information. - Detailed Pathology section describes common neoplasms in horses, cites research literature, and describes what is generally known about each condition. - Authoritative, inclusive, and unique coverage is likely to remain the standard reference for years to come. - Expert authors are recognized as the top experts in the field of equine oncology. - Practical, colorful design includes icon-based references for quick appraisal of prevalence and prognosis. |
| dendritic cell therapy cost: Cell Therapy Adrian P. Gee, 2021-11-10 This new edition presents a fully-updated and expanded look at current Good Manufacturing Practice (cGMP) for cell therapy products. It provides a complete discussion of facility design and operation including details specific to cord blood banking, cell processing, vector production and qualification of a new facility. Several chapters cover facility infrastructure including cleaning and maintenance, vendor qualification, writing a Standard Operating Procedure, staff training, and process validation. The detailed and invaluable product information covers topics like labelling, release and administration, transportation and shipment, et al. Further chapters cover relevant topics like writing and maintaining investigational new drug applications, support opportunities in North America and the European Union, commercial cell processing and quality testing services, and financial considerations for academic GMP facilities. A chapter on future directions rounds out Cell Therapy: cGMP Facilities and Manufacturing making it essential reading for any cell therapy professional involved in the development, use, or management of this type of facility. |
| dendritic cell therapy cost: Translating Gene Therapy to the Clinic Jeffrey Laurence, Michael Franklin, 2014-11-14 Translating Gene Therapy to the Clinic, edited by Dr. Jeffrey Laurence and Michael Franklin, follows the recent, much-lauded special issue of Translational Research in emphasizing clinical milestones and critical barriers to further progress in the clinic. This comprehensive text provides a background for understanding the techniques involved in human gene therapy trials, and expands upon the disease-specific situations in which these new approaches currently have the greatest therapeutic application or potential, and those areas most in need of future research. It emphasizes methods, tools, and experimental approaches used by leaders in the field of translational gene therapy. The book promotes cross-disciplinary communication between the sub-specialties of medicine, and remains unified in theme. - Presents impactful and widely supported research across the spectrum of science, method, implementation and clinical application - Offers disease-based coverage from expert clinician-scientists, covering everything from arthritis to congestive heart failure, as it details specific progress and barriers for current translational use - Provides key background information from immune response through genome engineering and gene transfer, relevant information for practicing clinicians contemplating enrolling patients in gene therapy trials |
| dendritic cell therapy cost: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance Silvia Beatriz Boscardin, Diana Dudziak, Daniela Santoro Rosa, Christian Muenz, 2020-12-10 This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact. |
| dendritic cell therapy cost: Towards Host-Directed Drug Therapies for Infectious and Non-Communicable Diseases Frank Brombacher, Abhay Satoskar, Alessandro Marcello, 2019-11-25 |
| dendritic cell therapy cost: Introduction to Stem Cell Science ReachBio, LLC, 2023-07-06 Stem cells have captured the public’s attention for years, particularly since the first human embryonic stem cell lines were derived in the laboratory in 1998. The field of stem cell science includes a wide range of disciplines, from basic biology to potential clinical treatments and drug development applications. The purpose of this well-illustrated volume is to provide a reader with no background in stem cell science an opportunity to learn about the broad range of stem cell types, the research being conducted and the potential of these fascinating cells to help improve human health. This introductory text, written by experts in the field, gives a broad overview of the field of stem cell science, including discussions of the different types of stem cells, the ethical considerations of the science, potential applications of stem cells to improving human health, how these cells will help us better understand human biology and disease processes, and how to critically read and understand the information available from a variety of sources. The authors clearly present the information on the broad field of stem cell science, including a discussion of why this exciting field has captured the imagination of the public and the media. The book also includes informative sections on the different types of stem cells, what stem cell research is really like, and the progress that has been made developing methods to prevent and treat disease using stem cell-based technologies. Anyone who is interested in learning the basics of stem cells and how they are used should read this book. |
| dendritic cell therapy cost: Transplant Infections Raleigh A. Bowden, Per Ljungman, David R. Snydman, 2012-03-28 Transplant Infections is a practical, clinically focused reference covering the common and more unusual bacterial, viral, and fungal infections affecting patients who have received stem cell or solid organ transplants. It provides a comprehensive review of the epidemiology, diagnosis, and management of opportunistic infections and presents strategies for infection prevention and control. Highlights of the Third Edition include a chapter on new immunosuppressive agents and expanded coverage of tropical infections and West Nile virus. |
| dendritic cell therapy cost: Business for a Lady, or My Life in Medical Tourism Tatiana Sokoloff, 2022-05-15 First book of the Founder and CEO of MedicaTour, one of the leading players in the medical tourism market.In the book, the author shares his work experience, ups and downs, gives practical advices on the development and organization of business.The book can be recommended as a study guide on medical tourism. |
| dendritic cell therapy cost: Immunology for Engineers , 2024-05-17 Immunology for Engineers, Volume 140 consists of chapters from stalwarts of the field, covering topics such as antibody engineering, adjuvant requirement and its methodology for assessment, and the need to develop immunotherapy, etc. Chapters covered in this volume discuss Current Status and Future Prospective of Breast Cancer Immunotherapy, Engineering high affinity antigen binders- beyond antibodies, Platelets and Inter-Cellular Communication in Immune Responses: Dialogue with both Professional and Non-Professional Immune Cells, Chimeric Antigen Receptor (CAR) T cell-based cancer immunotherapy: A boon for cancer-free life, and Molecular insights and promise of Oncolytic Virus based Immunotherapy. - Presents the latest in immunological engineering - Delves into timely topics such as antibody engineering - Covers vaccine engineering amongst many other important topics |
| dendritic cell therapy cost: Holland-Frei Cancer Medicine Robert C. Bast, Jr., Carlo M. Croce, William N. Hait, Waun Ki Hong, Donald W. Kufe, Martine Piccart-Gebhart, Raphael E. Pollock, Ralph R. Weichselbaum, Hongyang Wang, James F. Holland, 2017-03-20 Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients. A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs Includes free access to the Wiley Digital Edition providing search across the book, the full reference list with web links, illustrations and photographs, and post-publication updates |
| dendritic cell therapy cost: Stem Cells and Cancer Stem Cells, Volume 9 M.A. Hayat, 2012-12-22 This fresh addition to the rapidly expanding Springer series on stem cells represents an additional forward step in our understanding of the causes, diagnosis, and cell-related therapies of major human diseases as well as debilitating injuries to human tissue and organs. Showcasing the work of more than 80 contributors from 13 nations, it offers an unrivalled breadth of differing perspectives on the subject, with dedicated sections covering umbilical cord, induced pluripotent, embryonic, and hematopoietic stem cells, in addition to stem cells in tumors and cancer, and the applications of stem cells in regenerative medicine. Enhanced by numerous color illustrations and tables that provide graphic clarification and summaries of key results, the volume succeeds in bringing together research results from oncologists, neurosurgeons, physicians, research scientists, and pathologists, whose accumulated wealth of practical experience will inform and inspire further developments in the vital and urgent work of cancer diagnosis, cure, and prevention. |
| dendritic cell therapy cost: Bioprocessing for Cell-Based Therapies Che J. Connon, 2017-03-01 With contributions from leading, international academics and industrial practitioners, Bioprocessing for Cell-Based Therapies explores the very latest techniques and guidelines in bioprocess production to meet safety, regulatory and ethical requirements, for the production of therapeutic cells, including stem cells. An authoritative, cutting-edge handbook on bioprocessing for the production of therapeutic cells with extensive illustrations in full colour throughout An authoritative, cutting-edge handbook on bioprocessing for the production of therapeutic cells with extensive illustrations in full colour throughout In depth discussion of the application of cell therapy including methods used in the delivery of cells to the patient Includes contributions from experts in both academia and industry, combining a practical approach with cutting edge research The only handbook currently available to provide a state of the art guide to Bioprocessing covering the complete range of cell-based therapies, from experts in academia and industry |
| dendritic cell therapy cost: Gene and Cell Therapy Nancy Smyth Templeton, 2003-12-17 This reference is completely revised and expanded to reflect the most critical studies, controversies, and technologies impacting the medical field, including probing research on lentivirus, gutless adenovirus, bacterial and baculovirus vectors, retargeted viral vectors, in vivo electroporation, in vitro and in vivo gene detection systems, and all inducible gene expression systems. Scrutinizing every tool, technology, and issue impacting the future of gene and cell research, it is specifically written and organized for laymen, scholars, and specialists from varying backgrounds and disciplines to understand the current status of gene and cell therapy and anticipate future developments in the field. |
| dendritic cell therapy cost: Contemporary Targeted Therapies in Rheumatology Josef S. Smolen, Peter E. Lipsky, 2007-10-18 Targeted therapies of rheumatic diseases have become a reality and have completely changed patient care as well as patient expectations. Initial success with therapies aimed at blocking TNF and IL-1 has stimulated the development of additional targeted approaches focused on other cytokines as well as specific cells and pathways involved in the path |
| dendritic cell therapy cost: Advances in Precision Medicine Oncology Hilal Arnouk, Bassam Abdul Rasool Hassan, 2021 Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects. |
| dendritic cell therapy cost: Novel Developments in Stem Cell Mobilization Stefan Fruehauf, W. Jens Zeller, Gary Calandra, 2012-02-15 Recently the CXCR4/CXCL12-axis has been recognized as one of the pivotal adhesion pathways by which hematopoietic stem cells are retained in the bone marrow. CXCR4 antagonists with different chemical specification are being developed. Pharmacology research guides the way to the rational development effective antagonists. One antagonist, plerixafor, is clinically approved now for stem cell mobilization of lymphoma and myeloma patients. This allows patients to receive potentially life-saving treatment which could not have been administered otherwise. Through early clinical studies it was recognized that CXCR4 antagonists also mobilize malignant hematopoetic cells, i.e. leukemia cells. In preclinical studies a sensitization of mobilized leukemic cells to standard cytotoxic chemotherapy could be shown. Clinical studies are under way. CXCR4 antagonists are an exciting new class of compounds which are also employed for the mobilization of angiogenic cells or for the treatment of solid tumors. In this book a concise review of the current status of knowledge and future developments will be presented. |
| dendritic cell therapy cost: Guide to Cell Therapy GxP Joaquim Vives, Gloria Carmona, 2015-07-24 Guide to Cell Therapy GxP is a practical guide to the implementation of quality assurance systems for the successful performance of all cell-based clinical trials. The book covers all information that needs to be included in investigational medicinal product dossier (IMPD), the launching point for any clinical investigation, and beyond. Guide to Cell Therapy GxP bridges a knowledge gap with the inclusion of examples of design of GLP-compliant preclinical studies; design of bioprocesses for autologous/allogeneic therapies; and instruction on how to implement GLP/GMP standards in centers accredited with other quality assurance standards. Guide to Cell Therapy GxP is an essential resource for scientists and researchers in hospitals, transfusion centers, tissue banks, and other research institutes who may not be familiar with the good scientific practice regulations that were originally designed for product development in corporate environments. This book is also a thorough resource for PhD students, Post-docs, Principal Investigators, Quality Assurance Units, and Government Inspectors who want to learn more about how quality standards are implemented in public institutions developing cell-based products. - Easy access to important information on current regulations, state-of-the-art techniques, and recent advances otherwise scattered on various funding websites, within conference proceedings, or maintained in local knowledge - Features protocols, techniques for trouble-shooting common problems, and an explanation of the advantages and limitations of a technique in generating conclusive data - Includes practical examples of successful implementation of quality standards |
| dendritic cell therapy cost: Bone Cancer Dominique Heymann, 2014-09-04 Bone Cancer, Second Edition comprehensively investigates key discoveries in the field of bone biology over the last five years that have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Second Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with key chapters from the first edition, and offers numerous new chapters describing the new concepts of bone cancer biology and therapy, for both primary bone tumors as well as bone metastases. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases – from bench to bedside: development (cellular and molecular mechanisms), genomic and proteomic analyses, clinical analyses (histopathology, imaging, pain monitoring), as well as new therapeutic approaches and clinical trials for primary bone tumors and bone metastases. - Presents a comprehensive, translational source for all aspects of primary bone cancer and bone metastases in one reference work - Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system - Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases - Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays |
Dendritic Cell Therapy - Immucura
Dendritic cells (DC) are antigen-presenting cells that can communicate with T cells both directly and indirectly1, regulating our adaptive immune responses against cancer cells and tumours. …
Pricing Tolerance & the Evolution of Cell Therapy Costs of Care
May 6, 2021 · Costs in the inpatient hospital setting were $12561 for drugs, $15690 for procedures, and $53360 for hospitalization and office visits, for a total cost of $81611.
Immunotherapy with dendritic cells (DCT) - IASO Cancer
Immunization with dendritic cells is performed subcutaneously by the treating physician in the patient's groin region, after which the patient receives high-dose vitamin C infusions and can …
Landscape of cancer cell therapies: trends and real-world data …
By contrast, other cell therapies, including a variety of therapeutic agents different from T cells (such as dendritic cells, stem cells or myeloid cells, among others) grew by 129% this...
HEALTH TECHNOLOGY ASSESSMENT SECTION MEDICAL …
Dendritic Cell (DC) Therapy or so called Dendritic Cell vaccine is a newly emerging and potent form of immune therapy used to treat cancer, AIDS and other serious conditions. DENVAX ™ …
Pricing, Reimbursement and Market Access Trends for Cell
• Cell / gene therapies with highest annual visible ex-factory price are: • US was Rethymic (Allogeneic processed thymus tissue–agdc) at $2.7M • Europe was Libmeldy (atidarsagene …
A Global Cell Therapy CDMO - BioCentriq
Global CDMO specializing in cell banking and autologous and allogeneic cell therapies Patient-centricity is our commitment. Delivering excellence is our service promise. Strong strategic …
Designing a dendritic cell–based therapy for primary liver cancer
the use of adoptive therapy with T cells or dendritic cells (DCs) to stimulate more potent immune responses which selectively kill malignant cells expressing specific antigens. Tumour antigens …
Dendritic Cell Therapy - imcwc.com
Feb 2, 2023 · • Dendritic Cell Therapy harnesses the action of Dendritic Cells by identifying specific antigens on the cancer cells circulating in the blood of an individual, allowing the …
Overcome cancer from within Dendritic Cell Therapy DCT
3. How much does the DCT program cost? DCT is a private therapy, although an increasing number of health insurances might cover the associated costs. To receive an accurate cost …
Mustang Bio Receives Orphan Drug Designation for MB-102 …
Dec 20, 2018 · granted Orphan Drug Designation to MB-102 (CD123 CAR T) for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and incurable blood cancer with …
Manufacturing Dendritic Cells for Immunotherapy: Monocyte …
Monocyte-derived dendritic cells are generated from whole blood or apheresis products by culturing enriched monocytes in the presence of interleukin (IL)-4 and granulo-cyte …
Clinical development in dendritic cell based immunotherapy
Due to unique characteristics of the dendritic cell, Immunotherapy using dendritic cell therapy has emerged as one of the potent treatment options for solid tumors.
Best Dendritic Cell Therapy Laboratory 2021 - labor …
Countless research and therapy facilities around the world are increasingly turning to dendritic cell therapy, with more than 7,000 scientific papers having been published and the therapy having …
DENDRITIC CELL THERAPY
DENDRITIC CELL THERAPY PATIENT INFORMATION BOOKLET 04 The effectiveness of dendritic cell therapy Treatment with dendritic cells is used for all types of cancer, except for …
Dendritic cell therapy: a proactive approach against cancer …
Dendritic cells (DCs) play a central role in the initiation and regulation of innate and adaptive immune responses and have increasingly been applied as vaccines for cancer patients.
Dendritic cell vaccines as cancer treatment: focus on 13 years …
In particular, we decided to introduce cryopreservation of mDCs to optimize production in terms of time, cost, and reproducibility, all of which comply with GMP guidelines to guarantee the …
Dendritic Cell Therapy - immunyo.com
Dendritic Cell Therapy harnesses the remarkable ability of dendritic cells to activate the immune system and eliminate cancer cells. This therapy is a vital component of the latest …
An Entrepreneurial CDMO for Cell Therapy - biocentriq.com
Jun 1, 2024 · • 14 Grade-B/ISO-7 GMP suites designed for cell therapy manufacturing • Clinical through Commercial. 17-year track record • 18,000 commercial lots per year.
Cell-Based Therapy for Severe COVID-19 Patients: Clinical
For instance, a simple joint injection can cost approximately $1000, and the cost of high-level treatments can increase up to $100,000 depending on the condition. In this regard, Lopes et …
Dendritic Cell Therapy - Immucura
Dendritic cells (DC) are antigen-presenting cells that can communicate with T cells both directly and …
Pricing Tolerance & the Evolution of Cell Therapy C…
May 6, 2021 · Costs in the inpatient hospital setting were $12561 for drugs, $15690 for procedures, and $53360 …
Immunotherapy with dendritic cells (DCT) - IAS…
Immunization with dendritic cells is performed subcutaneously by the treating physician in the patient's …
Landscape of cancer cell therapies: trends and real-…
By contrast, other cell therapies, including a variety of therapeutic agents different from T cells (such as …
HEALTH TECHNOLOGY ASSESSMENT SECTION ME…
Dendritic Cell (DC) Therapy or so called Dendritic Cell vaccine is a newly emerging and potent form of …
